Drugs
Wal-Mart's Pharmacy Division recognized Eli Lilly and Company as its Vendor/Partner of the Year, citing the pharmaceutical company's commitment to delivering superior value and quality. The award was presented at Wal-Mart's world headquarters in Bentonville, Arkansas, in recognition of Lilly's excellence
Drugs
Genzyme Transgenics Corp. has announced a significant improvement in its financial performance for the first quarter of 1995. The company's net loss for the quarter was $2.3 million, down 29% from the previous quarter's net loss of $3.2 million. This improvement was driven by
Drugs
The April 6 ABC News special examining the harm reduction approach to the war on drugs, "America's War on Drugs: Searching for Solutions," has sparked a heated debate among experts and advocates. Those against drug legalization and decriminalization slammed the program as one-sided, while those in
Pharmaceutical industry
Salick Health Care Inc., a leading provider of diagnosis and treatment to patients with catastrophic illness, announced that its stockholders voted to approve its merger agreement with Zeneca Group PLC, a leading international bioscience and pharmaceutical company. The merger, consummated following the meeting, sees Salick Health Care issuing 50% of
Pharmaceutical industry
McKesson Corp. and Albertson's Inc. have solidified their partnership with a five-year, $1 billion contract for the supply of pharmaceuticals and other drug store items to Albertson's 455 supermarkets nationwide. This agreement highlights McKesson's commitment to providing value-added services, leveraging advanced technology to streamline
Drugs
Bayer Corporation, formerly known as Miles Inc., marked a significant milestone in its history by adopting the globally recognized name Bayer. This move allows the company to leverage its existing equity and assure customers worldwide of consistently high-quality products. Celebrations were held at over 50 sites across the U.S.
Drugs
Bayer, a global chemical and healthcare company, is constructing a new methylene diisocyanate (MDI) complex in Baytown, Texas, to increase its global capacity. The new facility will be completed in 1998 and will add over 300 million pounds to the company's annual capacity, making it the largest such
Drugs
Cortech Inc., a Denver-based biopharmaceutical firm, has announced the reduction of its staff by 34 employees, equivalent to 20% of its workforce, primarily due to decreasing activities in pilot-manufacturing and related functional areas. The restructuring aims to reduce spending and conserve cash, while still maintaining the ability to ramp up
Pharmaceutical industry
Pharmaceutical industry leaders, such as Dr. Armin Kessler, chief operating officer and member of the board for F. Hoffmann-La Roche, are advocating for a stronger role in healthcare discussions and policy reforms. Dr. Kessler emphasizes the need for industry to participate in a broad range of healthcare discussions, including a
Pharmaceutical industry
Pfizer, a leading pharmaceutical company, has recently entered four new biotechnology research collaborations as part of its overall investment strategy to expand its array of therapeutic opportunities and accelerate the discovery of new medicines. This strategic network of alliances, termed Pfizergen, will bolster and expand the company's existing
Pharmaceutical industry
Counsel Corporation, a Canadian company, today announced its 1994 financial results, which show a significant turnaround from the previous year. After a loss of $6.2 million in 1993, the company reported net earnings of $9.4 million in 1994, with earnings per share of 28 cents. This improvement is
Pharmaceutical industry
Fluor Daniel, a global engineering, construction, and diversified services company, has been awarded a contract by Banner Pharmacaps Inc. to develop a pharmaceutical facility and corporate headquarters in High Point, North Carolina. This project, valued at approximately $35 million, will create a 210,000-square-foot manufacturing facility for soft gelatin capsules
